We are using cookies to give you the best experience on our site. Cookies are files stored in your browser and are used by most websites to help personalise your web experience. By continuing to use our website without changing the settings, you are agreeing to our use of cookies.

  • Facebook
  • Twitter
  • Linked In
  • Google+
back top
Hollander Anthony

Head of Institute Hollander Anthony

Hollander Anthony

University of Liverpool
Institute of Integrative Biology
Liverpool, United Kingdom

Anthony Hollander is Head of The Institute of Integrative Biology at The University of Liverpool. He has many years of experience in cartilage biology and his research is particularly focused on osteoarthritis. He also has a more general expertise in the wider fields of stem cells and tissue engineering. His work includes a study on the regulation of stem cell differentiation for cartilage repair. In 2008, Professor Hollander and a team of scientists and surgeons successfully created and then transplanted the first tissue-engineered trachea (windpipe), using a patient’s own stem cells. The bioengineered trachea immediately provided the patient with a normally functioning airway, thereby saving her life. His research into meniscal cartilage repair has led to a Phase I/IIa trial of the “Cell Bandage” technology that is being developed by his spin out company, Azellon Cell Therapeutics.

In 2010 the “Times” newspaper ranking of Britains 100 most important scientists included him at 39th on the list.

Professor Anthony Hollander has been working in the field of cartilage biology and arthritis research for two decades. Three of those years were spent at the internationally recognised cartilage laboratory at McGill University in Montreal. More recently he has focused on tissue engineering and stem cell biology for cartilage repair.

Professor Hollander has received funding in excess of £5 million of peer-reviewed funding over the past 10 years from The UK government, medical charities, the EU framework programmes and from biotechnology companies. He has been the named inventor on several patents. He is co-founder and Scientific Director of a University of Bristol spin-out company, Azellon Cell Therapeutics.

His work includes a study on the regulation of stem cell differentiation for cartilage repair and has pioneered the development of new assays and methodological approaches